‘All-Comers' LEADERS試験における経皮的冠動脈介入を受ける患者のリスク評価における年齢、クレアチニン、および左室駆出率（ACEFスコア）の価値

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1. 1Evaluating the added predictive ability of a new marker: From area under the ROC curve to reclassification and beyond2007 · 6,312 citations
2. 2A New Tool for the Risk Stratification of Patients With Complex Coronary Artery Disease2010 · 259 citations
3. 3Value of the SYNTAX Score for Risk Assessment in the All-Comers Population of the Randomized Multicenter LEADERS (Limus Eluted from A Durable versus ERodable Stent coating) Trial2010 · 220 citations
4. 4Percutaneous Coronary Intervention versus Coronary-Artery Bypass Grafting for Severe Coronary Artery Disease2009 · 4,334 citations
5. 5Biolimus-eluting stent with biodegradable polymer versus sirolimus-eluting stent with durable polymer for coronary revascularisation (LEADERS): a randomised non-inferiority trial2008 · 652 citations